A Bridging Study of Efsubaglutide Alfa in Healthy Adults in Brazil

NCT07518121 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Diabete Type 2

Interventions

DRUG: Efsubaglutide Alfa Injection
DRUG: Placebo

Sponsor

Shanghai Yinnuo Pharmaceutical Technology Co., Ltd.